IL171987A0 - The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma - Google Patents
The use of fumaric acid derivatives for treating cardiac insufficiency, and asthmaInfo
- Publication number
- IL171987A0 IL171987A0 IL171987A IL17198705A IL171987A0 IL 171987 A0 IL171987 A0 IL 171987A0 IL 171987 A IL171987 A IL 171987A IL 17198705 A IL17198705 A IL 17198705A IL 171987 A0 IL171987 A0 IL 171987A0
- Authority
- IL
- Israel
- Prior art keywords
- fumaric acid
- acid derivatives
- asthma
- cardiac insufficiency
- treating cardiac
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
Abstract
FIELD: medicine, pharmaceutics. ^ SUBSTANCE: what is presented is using fumaric acid derivatives specified in a group consisting of dialkylfumarates, monoalkylhydrofumarates, fumaric acid monoalkyl ester salts, fumaric acid monoamides, fumaric acid monoamide salts, fumaric acid diamides, monoalkyl monoamido fumarates, carbocyclic and oxacarbocyclic oligomers of these compounds or their mixtures for preparing a drug for treatment or prevention of cardiac failure, particularly left-ventricular failure, myocardial infarction and angina. ^ EFFECT: dimethylfumarate has appeared to reduce considerably an area of infarction caused by ischemia followed by reperfusion. ^ 19 cl, 4 dwg, 7 ex
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10341530 | 2003-09-09 | ||
DE10360869A DE10360869A1 (en) | 2003-09-09 | 2003-12-23 | Use of fumaric acid derivatives for the treatment of heart failure, hyperkeratosis and asthma |
PCT/EP2004/009835 WO2005023241A1 (en) | 2003-09-09 | 2004-09-03 | The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma |
Publications (2)
Publication Number | Publication Date |
---|---|
IL171987A0 true IL171987A0 (en) | 2006-04-10 |
IL171987A IL171987A (en) | 2010-12-30 |
Family
ID=34258515
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL171987A IL171987A (en) | 2003-09-09 | 2005-11-15 | Use of fumaric acid derivatives for preparing a drug for treating or prevention of cardiac insufficiency, myocardial infarct and angina pectoris |
Country Status (12)
Country | Link |
---|---|
JP (3) | JP2008529959A (en) |
CN (2) | CN1829505B (en) |
AT (1) | ATE447946T1 (en) |
CY (1) | CY1107849T1 (en) |
DE (2) | DE10360869A1 (en) |
HK (1) | HK1094650A1 (en) |
IL (1) | IL171987A (en) |
NZ (1) | NZ543708A (en) |
PT (1) | PT1663197E (en) |
RS (1) | RS51881B (en) |
RU (2) | RU2459621C2 (en) |
ZA (1) | ZA200601985B (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2650279A3 (en) | 2008-08-19 | 2014-02-12 | XenoPort, Inc. | Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use |
PT2379063E (en) * | 2009-01-09 | 2013-05-03 | Forward Pharma As | Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix |
HK1252751A1 (en) * | 2009-01-09 | 2019-05-31 | Fwp Ip Aps | Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix |
EP2782561A1 (en) * | 2011-11-24 | 2014-10-01 | Synthon BV | Controlled release particles comprising dimethyl fumarate |
CN114146080A (en) * | 2012-02-07 | 2022-03-08 | 比奥根玛公司 | Pharmaceutical composition containing dimethyl fumarate |
AU2013305684B2 (en) | 2012-08-22 | 2016-11-24 | Xenoport, Inc. | Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof |
WO2014031844A1 (en) | 2012-08-22 | 2014-02-27 | Xenoport, Inc. | Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects |
KR101379427B1 (en) * | 2013-02-13 | 2014-03-28 | 경북대학교병원 | Composition for preventing or treating renal fibrosis comprising dimethylfumarate |
US10179118B2 (en) | 2013-03-24 | 2019-01-15 | Arbor Pharmaceuticals, Llc | Pharmaceutical compositions of dimethyl fumarate |
WO2014197860A1 (en) | 2013-06-07 | 2014-12-11 | Xenoport, Inc. | Method of making monomethyl fumarate |
US9421182B2 (en) | 2013-06-21 | 2016-08-23 | Xenoport, Inc. | Cocrystals of dimethyl fumarate |
TW201516020A (en) | 2013-09-06 | 2015-05-01 | Xenoport Inc | Crystalline forms of (N,N-diethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioate, methods of synthesis and use |
US20150079180A1 (en) * | 2013-09-18 | 2015-03-19 | Xenoport, Inc. | Nanoparticle compositions of dimethyl fumarate |
US9999672B2 (en) | 2014-03-24 | 2018-06-19 | Xenoport, Inc. | Pharmaceutical compositions of fumaric acid esters |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5242905A (en) * | 1987-09-04 | 1993-09-07 | Dexter Chemical Corporation | Pharmaceutical compositions for the treatment of psoriasis |
US4959389A (en) * | 1987-10-19 | 1990-09-25 | Speiser Peter P | Pharmaceutical preparation for the treatment of psoriatic arthritis |
WO1998027970A2 (en) * | 1996-12-24 | 1998-07-02 | National Research Council Of Canada | Treatment of diseases or prevention of cellular damage caused by oxygen-containing free radicals |
DE19721099C2 (en) * | 1997-05-20 | 1999-12-02 | Fumapharm Ag Muri | Use of fumaric acid derivatives |
DE19814358C2 (en) * | 1998-03-31 | 2002-01-17 | Fumapharm Ag Muri | Use of alkyl hydrogen fumarates for the treatment of psoriasis, psoriatic arthritis, neurodermatitis and enteritis regionalis Crohn |
DE19839566C2 (en) * | 1998-08-31 | 2002-01-17 | Fumapharm Ag Muri | Use of fumaric acid derivatives in transplant medicine |
DE19853487A1 (en) * | 1998-11-19 | 2000-05-25 | Fumapharm Ag Muri | Use of dialkyl fumarate for treating transplant rejection and autoimmune disease |
WO2002055063A2 (en) * | 2001-01-12 | 2002-07-18 | Fumapharm Ag | Fumaric acid amides |
DE10101307A1 (en) * | 2001-01-12 | 2002-08-01 | Fumapharm Ag Muri | Fumaric acid derivatives as NF-kappaB inhibitor |
RU2189813C1 (en) * | 2001-06-01 | 2002-09-27 | Российский научно-исследовательский институт гематологии и трансфузиологии | Antihypoxic medicinal agent |
DE10217314A1 (en) * | 2002-04-18 | 2003-11-13 | Fumapharm Ag Muri | Carbocyclic and oxacarboncyclic fumaric acid oligomers |
-
2003
- 2003-12-23 DE DE10360869A patent/DE10360869A1/en not_active Withdrawn
-
2004
- 2004-09-03 AT AT07121903T patent/ATE447946T1/en not_active IP Right Cessation
- 2004-09-03 CN CN2004800217249A patent/CN1829505B/en not_active Expired - Fee Related
- 2004-09-03 NZ NZ543708A patent/NZ543708A/en unknown
- 2004-09-03 RS YU20050948A patent/RS51881B/en unknown
- 2004-09-03 PT PT04764790T patent/PT1663197E/en unknown
- 2004-09-03 CN CN2010102746278A patent/CN102058574B/en not_active Expired - Fee Related
- 2004-09-03 JP JP2006515290A patent/JP2008529959A/en active Pending
- 2004-09-03 DE DE602004024143T patent/DE602004024143D1/en active Active
-
2005
- 2005-11-15 IL IL171987A patent/IL171987A/en not_active IP Right Cessation
-
2006
- 2006-03-08 ZA ZA200601985A patent/ZA200601985B/en unknown
-
2007
- 2007-02-14 HK HK07101740.4A patent/HK1094650A1/en not_active IP Right Cessation
- 2007-10-15 RU RU2007138216/15A patent/RU2459621C2/en not_active IP Right Cessation
-
2008
- 2008-01-08 CY CY20081100024T patent/CY1107849T1/en unknown
-
2009
- 2009-12-24 JP JP2009292569A patent/JP5784877B2/en not_active Expired - Fee Related
-
2012
- 2012-04-19 RU RU2012115860/15A patent/RU2012115860A/en not_active Application Discontinuation
-
2015
- 2015-06-04 JP JP2015113701A patent/JP2015155480A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2008529959A (en) | 2008-08-07 |
CN1829505B (en) | 2010-11-10 |
RU2007138216A (en) | 2009-04-20 |
JP2015155480A (en) | 2015-08-27 |
PT1663197E (en) | 2007-12-26 |
DE602004024143D1 (en) | 2009-12-24 |
CN102058574B (en) | 2013-02-13 |
JP2010070563A (en) | 2010-04-02 |
RS51881B (en) | 2012-02-29 |
RU2459621C2 (en) | 2012-08-27 |
HK1094650A1 (en) | 2007-04-04 |
IL171987A (en) | 2010-12-30 |
DE10360869A1 (en) | 2005-04-07 |
CN1829505A (en) | 2006-09-06 |
RU2012115860A (en) | 2013-10-27 |
RS20050948A (en) | 2008-04-04 |
ATE447946T1 (en) | 2009-11-15 |
JP5784877B2 (en) | 2015-09-24 |
CN102058574A (en) | 2011-05-18 |
NZ543708A (en) | 2008-11-28 |
ZA200601985B (en) | 2007-05-30 |
CY1107849T1 (en) | 2013-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL171987A0 (en) | The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma | |
AU2016366220B2 (en) | Compounds useful in the treatment and/or care of the skin, hair, nails, and/or mucous membranes | |
EA200101166A1 (en) | Metalloprotease inhibitors | |
MXPA03010435A (en) | Carboxylic acid substituted oxazole derivatives for use as ppar-alpha and -gamma activators in the treatment of diabetes. | |
CA2414967A1 (en) | Valproic acid and derivatives thereof as histone deacetylase inhibitors | |
TR200200648T2 (en) | New dicarboxylic acid derivatives with pharmaceutical properties. | |
EP1592665A4 (en) | Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity | |
RU94040170A (en) | Isoquinolines | |
SG154333A1 (en) | The use of substituted cyanopyrrolidines and combination preparations containing them for treating hyperlipidemia and associated diseases | |
EA200801492A1 (en) | PHARMACEUTICAL APPLICATION OF SUBSTITUTED AMIDES | |
MY146662A (en) | Novel n-(8-heteroaryltetrahydronaphtalene-2yl) or n-(5-heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain | |
DE60045508D1 (en) | DALDA ANALOGS AND THEIR USE | |
AR036623A1 (en) | REPAGLINIDA PREPARATION PROCESS | |
ES2163805T3 (en) | DERIVATIVES OF BENZOFURAN-ACRYLIC ACIDS AND ITS USE AS MODULATORS OF RXRS OR RARS RECEIVERS. | |
CA2362833A1 (en) | Phenylalaninol derivatives | |
ATE325809T1 (en) | AMIDE DERIVATIVES OF 2-AMINO-3-HYDROXY-4-TERT-LEUCYL-AMINO-5-PHENYL-PENTORIC ACID | |
GEP20053636B (en) | Isoquinoline Compounds, Process for Their Preparation and Pharmaceutical Compositions Containing Them | |
TR200101980T2 (en) | Arilalkanoil derivatives, their preparation processes | |
GEP20043226B (en) | C7 Carbonate Substituted Taxanes as Antitumor Agents, Pharmaceutical Compositions Containing the Same and Use Thereof as Agents to Inhibit Tumor Growth | |
TW200500342A (en) | 2-(butyl-1-sulfonylamino)-n-[1(r)-(6-methoxypyridin-3-yl)propyl]benz-amide, its use as a medicament, and pharmaceutical preparations comprising it | |
AR030945A1 (en) | AMIDAS OF FENILCICLOHEXANOCARBOXILICO SUBSTITUTED ACID AND USE | |
MX2009005676A (en) | Dialkylamino alkyl esters of pivagabine as medicaments for the treatment of central nervous system disorders. | |
ATE546137T1 (en) | PHARMACEUTICAL COMPOSITIONS FOR TREATING WARTS | |
ES2385683A1 (en) | Compositions for the treatment of pain and/or inflammation. (Machine-translation by Google Translate, not legally binding) | |
SI1546083T1 (en) | Novel substituted arylhexadienoic acids and esters thereof which can be used for the treatment and prevention of diabetes, dyslipidaemia and atherosclerosis, pharmaceutical compositions comprising them and processes for the preparation of them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |